- Home
- CZFS vs REPL Comparison
CZFS vs REPL Comparison
Compare CZFS & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZFS
- REPL
- Stock Information
- Founded
- CZFS 1984
- REPL 2015
- Country
- CZFS United States
- REPL United States
- Employees
- CZFS N/A
- REPL N/A
- Industry
- CZFS Major Banks
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- CZFS Finance
- REPL Health Care
- Exchange
- CZFS Nasdaq
- REPL Nasdaq
- Market Cap
- CZFS 291.1M
- REPL 239.0M
- IPO Year
- CZFS N/A
- REPL 2018
- Fundamental
- Price
- CZFS $53.69
- REPL $7.03
- Analyst Decision
- CZFS
- REPL Buy
- Analyst Count
- CZFS 0
- REPL 10
- Target Price
- CZFS N/A
- REPL $8.25
- AVG Volume (30 Days)
- CZFS 10.3K
- REPL 21.4M
- Earning Date
- CZFS 07-30-2025
- REPL 08-11-2025
- Dividend Yield
- CZFS 3.68%
- REPL N/A
- EPS Growth
- CZFS 15.27
- REPL N/A
- EPS
- CZFS 6.58
- REPL N/A
- Revenue
- CZFS $103,858,000.00
- REPL N/A
- Revenue This Year
- CZFS N/A
- REPL N/A
- Revenue Next Year
- CZFS $5.45
- REPL $194.05
- P/E Ratio
- CZFS $8.09
- REPL N/A
- Revenue Growth
- CZFS 5.78
- REPL N/A
- 52 Week Low
- CZFS $41.20
- REPL $2.68
- 52 Week High
- CZFS $75.40
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- CZFS 34.42
- REPL 46.68
- Support Level
- CZFS $58.52
- REPL $3.02
- Resistance Level
- CZFS $62.01
- REPL $8.07
- Average True Range (ATR)
- CZFS 2.01
- REPL 0.90
- MACD
- CZFS -0.90
- REPL -0.32
- Stochastic Oscillator
- CZFS 30.65
- REPL 41.19
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.